Vascular thrombosis, a important medical concern, necessitates prompt removal of blood clots to revive blood circulation. A standard intervention strategy is intravenous infusion of tissue plasminogen activator (tPA), but its quick fifty percent-existence and susceptibility to inactivation by inhibitors pose issues, resulting in superior doses that